VEGFA and persistent truncus arteriosus: In our study, we found that treatment with QSYQ significantly attenuates cardiac apoptosis and cardiac fibrosis in TAC-induced heart failure, which was accompanied by an upregulation of VEGF expression levels and maintenance of microvessel density in the heart.